SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008322
Filing Date
2017-11-07
Accepted
2017-11-07 08:02:08
Documents
73
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20170930x10q.htm 10-Q 2102434
2 EX-10.1 kala-20170930ex101a89fa2.htm EX-10.1 188981
3 EX-31.1 kala-20170930ex311fc631e.htm EX-31.1 21345
4 EX-31.2 kala-20170930ex312c0e435.htm EX-31.2 21343
5 EX-32.1 kala-20170930ex321373006.htm EX-32.1 9013
6 EX-32.2 kala-20170930ex322d28a47.htm EX-32.2 9430
7 GRAPHIC kala20170930ex101a89fa2001.jpg GRAPHIC 5453
8 GRAPHIC kala20170930ex101a89fa2002.jpg GRAPHIC 8964
  Complete submission text file 0001558370-17-008322.txt   7871399

Data Files

Seq Description Document Type Size
9 EX-101.INS kala-20170930.xml EX-101.INS 1721464
10 EX-101.SCH kala-20170930.xsd EX-101.SCH 42520
11 EX-101.CAL kala-20170930_cal.xml EX-101.CAL 37465
12 EX-101.DEF kala-20170930_def.xml EX-101.DEF 189652
13 EX-101.LAB kala-20170930_lab.xml EX-101.LAB 395217
14 EX-101.PRE kala-20170930_pre.xml EX-101.PRE 331023
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 171181163
SIC: 2834 Pharmaceutical Preparations